BDSX Biodesix Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Strobeck Matthew	2. Issuer Name and Ticker or Trading Symbol BIODESIX INC [ BDSX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) 2970 WILDERNESS PLACE, SUITE 100	3. Date of Earliest Transaction (MM/DD/YYYY) 12/30/2021
(Street) BOULDER, CO 80301 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/30/2021		P		138700	A	$4.35	211200	I (1)	By Birchview Fund LLC (1)
Common Stock	12/30/2021		P		9100	A	$4.35	19933	I (1)	By Birchview Capital Separately Managed Account (1)
Common Stock								966883 (4)	D
Common Stock								3518 (5)	I (2)	By UGMA Account (2)
Common Stock								3518 (5)	I (2)	By UGMA Account (2)
Common Stock								3518 (5)	I (2)	By UGMA Account (2)
Common Stock								3518 (5)	I (2)	By UGMA Account (2)
Common Stock								40665 (6)	I (3)	By Clajer Capital LLC (3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:
(1)	The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
(2)	The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
(3)	The reporting person is an affiliate of Clajer Capital LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
(4)	In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as directly held was inadvertently overstated by 92 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned directly by the reporting person.
(5)	In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as held by each UGMA Account was inadvertently overstated by 4 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by each UGMA Account.
(6)	In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as held by Clajer Capital LLC was inadvertently overstated by 22 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by Clajer Capital LLC.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Strobeck Matthew 2970 WILDERNESS PLACE SUITE 100 BOULDER, CO 80301	X

Signatures
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck		1/4/2022
**Signature of Reporting Person		Date